Overactive Bladder Treatment Market to Witness Massive Growth with Urovant Sciences receiving the U.S. FDA approval for its Gemtsea indicated for treatment of overactive bladder treatment
Overactive bladder is a composite of several symptoms that may make you have to urinate excessively, have less pressure, experience incontinence (leakage) more often, and have a strong desire to urinate at night. One or more of these common symptoms can cause significant psychological stress and an adverse impact on your quality of living. The most common triggers of overactive bladder are the urge to urinate or passing urine while asleep, sexual activity with multiple partners, and straining during bowel movements. Rising geriatric population and increasing prevalence of diseases causing overactive bladder are expected to drive growth of the global overactive bladder treatment market . According to the World Health Organization (WHO), by 2050, the global population aged 65 years and above is expected to reach around 2 billion increasing from 900 million in 2015. Furthermore, there are several diseases and disorders that cause overactive bladder including Parkinson’s dis...